↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.6MSold on the market
1Companies
Oct 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202616:07 | Oct 5, 2026 | PCVXVaxcyte, Inc. | SVP, Finance & CAO | S · Sell10b5-1 | $86.74 | −19,000 | 27,860 | -41% | −$1.6M | ||
| Oct 7, 202616:07 | Oct 5, 2026 | PCVXVaxcyte, Inc. | SVP, Finance & CAO | M · Exercise10b5-1 | $25.92 | +19,000 | 46,860 | +68% | $492K | ||
| Sep 9, 202617:52 | Sep 8, 2026 | PCVXVaxcyte, Inc. | SVP, Finance & CAO | F · Tax | $60.36 | −1,327 | 27,860 | -5% | $80K | ||
| Sep 2, 202619:54 | Sep 2, 2026from Aug 31, 2026 | PCVXVaxcyte, Inc. | SVP, Finance & CAO | F · Tax | $61.22 | −569 | 29,187 | -2% | $35K |